21 December 2021
Older patients in hospitals across China took part in a major multi-centre open-label randomised clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture.
20 December 2021
Adam Cunningham, Professor of Functional Immunity, speculates on how might the Omicron variant might affect future COVID-19 variants.
20 December 2021
A University of Birmingham-led study shows an increased risk of patients developing illnesses including mental ill-health and heart conditions if they have a GP-inputted medical history of gum disease.
20 December 2021
The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
20 December 2021
A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
20 December 2021
An additional 100,000 elective operations could be cancelled in England this winter as a result of the Omicron wave leading to increased hospital admissions.
10 December 2021
A new clinical trial being led by the University of Birmingham and funded by the British Heart Foundation could help improve the recovery of children who undergo life-saving heart surgery.
09 December 2021
Elderly care home residents who have previously contracted and survived COVID-19 develop much stronger and higher antibody and cellular immune responses to two doses of vaccination, research finds.
07 December 2021
CARE Fertility has generously donated £202,800 to support the miscarriage research led by Professor Arri Coomarasamy and team at the University of Birmingham.
03 December 2021
A UK-wide trial carried out in collaboration with the University of Birmingham show six COVID-19 vaccines are safe and boost immunity for people who have had two doses of Pfizer/BioNTech or Oxford/AstraZeneca.
29 November 2021
The University of Birmingham and Huazhong University of Science and Technology (HUST) have signed a 'Key Partner' agreement that paves the way for a growth in their collaborations in both teaching and research.
26 November 2021
LifeArc and PSC Support jointly award £898,774 for new research into primary sclerosing cholangitis (PSC), a rare disease where the body attacks its own liver, causing inflammation and scarring of the bile ducts.